When people with psoriatic arthritis begin to experience moderate or severe symptoms and do not respond well to other treatments, psoriatic arthritis injections are available. In this article, we'll ...

It is more than 99% effective. The contraceptive injection, or the shot, is a progestin-only birth control drug. It is long-acting and reversible. The name of the drug is Depo-Provera, also known ...

Astute Analytica has released a comprehensive report titled North American & European Methylnaltrexone Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032. This ...

Many oral systems also fail to achieve bioavailability levels comparable to those of subcutaneous injections. Furthermore, although robotic and autonomous devices have shown some success with self ...

Some patients report difficulty remembering to take something every day, and for them, “it’s easier to take the weekly injection,” Butsch said. While historically, people have been hesitant ...

especially for chronic conditions that require drugs to be taken frequently and that currently depend on intravenous infusions or intramuscular and subcutaneous injections. It also has the ...

A decade af­ter Keytru­da hit the mar­ket, Mer­ck has now said a sub­cu­ta­neous ver­sion of the im­munother­a­py passed a ...

Two months after Roche scored FDA approval for its subcutaneous version of PD-LI inhibitor Tecentriq, Merck has achieved a key milestone in lining up its checkpoint inhibitor Keytruda to follow suit.

Seeking to extend the reign of cancer king Keytruda, Merck has shown that a subcutaneous version of the anti-PD-1 therapy performs as well as the more invasive infusion formulation in a Phase III ...

The trial is evaluating the noninferiority of subcutaneous administration of pembrolizumab, Merck’s anti-PD-1 therapy, available for intravenous use as KEYTRUDA ®, together with ...

The trial is evaluating the noninferiority of subcutaneous administration of pembrolizumab, Merck’s anti-PD-1 therapy, available for intravenous use as KEYTRUDA ®, together with berahyaluronidase alfa ...

The fat injections, which caused his face to swell to the point where he couldn’t see, were the latest effort in Bryan Johnson’s “Project Blueprint.” The 47-year-old has enlisted 30 ...